Accuracy of N‐terminal‐pro‐atrial natriuretic peptide in patients admitted to emergency department

References

• Rademaker M. T., Richards A. M. Cardiac natriuretic peptides for cardiac health. Clin Sci (Lond) 2005; 108: 23–36
   PubMed Web of Science ®Google Scholar
• Abassi Z., Karram T., Ellaham S., Winaver J., Hoffman A. Implications of the natriuretic peptide system in the pathogenesis of heart failure: diagnostic and therapeutic importance. Pharmacol Ther 2004; 102: 223–41
   PubMed Web of Science ®Google Scholar
• Goetze J. P., Friis‐Hansen L., Rehfeld J. F., Nilsson B., Svendsen J. H. Atrial secretion of B‐type natriuretic peptide. Eur Heart J 2006; 27: 1648–50
   PubMed Web of Science ®Google Scholar
• Goetze J. P. Biochemistry of pro‐B‐type natriuretic peptide‐derived peptides: the endocrine heart revisited. Clin Chem 2004; 50: 1503–10
   PubMed Web of Science ®Google Scholar
• Mueller T., Gegenhuber A., Poelz W., Haltmayer M. Diagnostic accuracy of B type natriuretic peptide and amino terminal proBNP in the emergency diagnosis of heart failure. Heart 2005; 91: 606–12
   PubMed Web of Science ®Google Scholar
• Morrison L. K., Harrison A., Krishnaswamy P., Kazanegra R., Clopton P., Maisel A. Utility of a rapid B‐natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea. J Am Coll Cardiol 2002; 39: 202–9
   PubMed Web of Science ®Google Scholar
• Januzzi J. L., Jr., Camargo C. A., Anwaruddin S., Baggish A. L., Chen A. A., Krauser D. G., et al. The N‐terminal Pro‐BNP investigation of dyspnea in the emergency department (PRIDE) study. Am J Cardiol 2005; 95: 948–54
   PubMed Web of Science ®Google Scholar
• Wang C. S., FitzGerald J. M., Schulzer M., Mak E., Ayas N. T. Does this dyspneic patient in the emergency department have congestive heart failure?. J Am Med Assoc 2005; 294: 1944–56
   PubMed Web of Science ®Google Scholar
• Mueller C., Scholer A., Laule‐Kilian K., Martina B., Schindler C., Buser P., et al. Use of B‐type natriuretic peptide in the evaluation and management of acute dyspnea. N Engl J Med 2004; 350: 647–54
   PubMed Web of Science ®Google Scholar
• Gegenhuber A., Struck J., Poelz W., Pacher R., Morgenthaler N. G., Bergmann A., et al. Midregional pro‐A‐type natriuretic peptide measurements for diagnosis of acute destabilized heart failure in short‐of‐breath patients: comparison with B‐type natriuretic peptide (BNP) and amino‐terminal proBNP. Clin Chem 2006; 52: 827–31
   PubMed Web of Science ®Google Scholar
• Bossuyt P. M., Reitsma J. B., Bruns D. E., Gatsonis C. A., Glasziou P. P., Irwig L. M., et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Standards for Reporting of Diagnostic Accuracy. Clin Chem 2003; 49: 1–6
   PubMed Web of Science ®Google Scholar
• Perrier A., Roy P. M., Sanchez O., Le Gal G., Meyer G., Gourdier A. L., et al. Multidetector‐row computed tomography in suspected pulmonary embolism. N Engl J Med 2005; 352: 1760–8
   PubMed Web of Science ®Google Scholar
• Van Beneden R., Gurne O., Selvais P. L., Ahn S. A., Robert A. R., Ketelslegers J. M., et al. Superiority of big endothelin‐1 and endothelin‐1 over natriuretic peptides in predicting survival in severe congestive heart failure: a 7‐year follow‐up study. J Card Fail 2004; 10: 490–5
   PubMed Web of Science ®Google Scholar
• Schoonjans F., Zalata A., Depuydt C. E., Comhaire F. H. MedCalc: a new computer program for medical statistics. Comput Methods Programs Biomed 1995; 48: 257–62
   PubMed Web of Science ®Google Scholar
• Hogenhuis J., Voors A. A., Jaarsma T., Hillege H. L., Boomsma F., van Veldhuisen D. J. Influence of age on natriuretic peptides in patients with chronic heart failure: a comparison between ANP/NT‐ANP and BNP/NT‐proBNP. Eur J Heart Fail 2005; 7: 81–6
   PubMed Web of Science ®Google Scholar
• Loke I., Squire I. B., Davies J. E., Ng L. L. Reference ranges for natriuretic peptides for diagnostic use are dependent on age, gender and heart rate. Eur J Heart Fail 2003; 5: 599–606
   PubMed Web of Science ®Google Scholar
• Emdin M., Passino C., Del Ry S., Prontera C., Galetta F., Clerico A. Influence of gender on circulating cardiac natriuretic hormones in patients with heart failure. Clin Chem Lab Med 2003; 41: 686–92
   PubMed Web of Science ®Google Scholar
• Mehra M. R., Uber P. A., Park M. H., Scott R. L., Ventura H. O., Harris B. C., et al. Obesity and suppressed B‐type natriuretic peptide levels in heart failure. J Am Coll Cardiol 2004; 43: 1590–5
   PubMed Web of Science ®Google Scholar
• Meleagros L., Ghatei M. A., Gibbs J. S., Bloom S. R. Pro‐atrial natriuretic peptide (1–98): the circulating cardiodilatin in man. Peptides 1989; 10: 545–50
   PubMed Web of Science ®Google Scholar
• Buckley M. G., Sagnella G. A., Markandu N. D., Singer D. R., MacGregor G. A. Concentrations of N‐terminal ProANP in human plasma: evidence for ProANP (1–98) as the circulating form. Clin Chim Acta 1990; 191: 1–14
   PubMed Web of Science ®Google Scholar
• Winters C. J., Sallman A. L., Meadows J., Rico D. M., Vesely D. L. Two new hormones: prohormone atrial natriuretic peptides 1–30 and 31–67 circulate in man. Biochem Biophys Res Commun 1988; 150: 231–6
   PubMed Web of Science ®Google Scholar
• Gower W. R., Jr., Chiou S., Skolnick K. A., Vesely D. L. Molecular forms of circulating atrial natriuretic peptides in human plasma and their metabolites. Peptides 1994; 15: 861–7
   PubMed Web of Science ®Google Scholar
• Maisel A. S., Koon J., Krishnaswamy P., Kazenegra R., Clopton P., Gardetto N., et al. Utility of B‐natriuretic peptide as a rapid, point‐of‐care test for screening patients undergoing echocardiography to determine left ventricular dysfunction. Am Heart J 2001; 141: 367–74
   PubMed Web of Science ®Google Scholar
• Selvais P. L., Donckier J. E., Robert A., Laloux O., van Linden F., Ahn S., et al. Cardiac natriuretic peptides for diagnosis and risk stratification in heart failure: influences of left ventricular dysfunction and coronary artery disease on cardiac hormonal activation. Eur J Clin Invest 1998; 28: 636–42
   PubMed Web of Science ®Google Scholar
• Hunt S. A., Abraham W. T., Chin M. H., Feldman A. M., Francis G. S., Ganiats T. G., et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2005; 112: e154–e235
   PubMed Web of Science ®Google Scholar
• Kucher N., Printzen G., Goldhaber S. Z. Prognostic role of brain natriuretic peptide in acute pulmonary embolism. Circulation 2003; 107: 2545–7
   PubMed Web of Science ®Google Scholar
• ten Wolde M., Tulevski I. I., Mulder J. W., Sohne M., Boomsma F., Mulder B. J., et al. Brain natriuretic peptide as a predictor of adverse outcome in patients with pulmonary embolism. Circulation 2003; 107: 2082–4
   PubMed Web of Science ®Google Scholar